Aqueous extracts of Eruca sativa leaves and methods for inhibiting growth of gram-positive bacteria and mycoplasma

US11191800B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11191800-B2
Application numberUS-201816149674-A
CountryUS
Kind codeB2
Filing dateOct 2, 2018
Priority dateOct 2, 2018
Publication dateDec 7, 2021
Grant dateDec 7, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention is directed to an aqueous extract of Eruca sativa (arugula) leaves that has antimicrobial activity on Gram-positive bacteria and mycoplasmas. The extract may be purified away from solid or insoluble components, standardized based on the weight of its non-aqueous or solid content, assayed for antimicrobial activity, and provided in an aseptic or sterile form for pharmaceutical use. It may be used to kill or inhibit the growth of microorganisms such as Gram positive bacteria, promote wound healing, or as prophylaxis against host colonization or infection by a microorganism.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for inhibiting the growth of a Gram positive bacterium, comprising: preparing an aqueous Eruca sativa extract by: grinding a sample consisting of dried leaves of a Eruca sativa plant, macerating the ground leaves of the Eruca sativa plant with an extractant consisting of water to extract the leaves of the Eruca sativa plant for a period of days at a temperature of about 25° C. to extract water-soluble components from the leaves of the Eruca sativa plant then filtering to form a first extract, concentrating the first extract under vacuum to produce the aqueous Eruca saliva extract in the form of a thick concentrated extract liquid, then dispensing an aqueous composition comprising the thick concentrated extract liquid from a dispenser in the form of a foam, contacting the Gram positive bacterium with the foam to inhibit the growth of the Gram positive bacterium, wherein the Gram positive bacterium is Cellulomonas strain B22. 2. The method of claim 1 , wherein the macerating is performed at a pH ranging from 6.0 to 6.5. 3. The method of claim 1 , wherein the foam contains at least 0.15 wt % of an Eruca sativa aqueous extract based on anhydrous weight or dry weight of the Eruca sativa extract. 4. The method of claim 1 , wherein contacting the Gram positive bacterium occurs in a skin, nail, or hair wound or injury. 5. The method of claim 1 , wherein contacting the Gram positive bacterium occurs in a wound or injury to a mucous membrane.

Assignees

Inventors

Classifications

  • Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title

  • A61K36/31Primary

    Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi · CPC title

  • A61P31/04Primary

    Antibacterial agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11191800B2 cover?
The invention is directed to an aqueous extract of Eruca sativa (arugula) leaves that has antimicrobial activity on Gram-positive bacteria and mycoplasmas. The extract may be purified away from solid or insoluble components, standardized based on the weight of its non-aqueous or solid content, assayed for antimicrobial activity, and provided in an aseptic or sterile form for pharmaceutical us…
Who is the assignee on this patent?
Univ Imam Abdulrahman Bin Faisal
What technology area does this patent fall under?
Primary CPC classification A61K36/31. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).